Obesity: open trials in China

237 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT07102251
A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects
Trial Treatment · Phase 1 · Sunshine Lake Pharma Co., Ltd.
The Second Affiliated Hospital of Anhui Medical University is a Grade A Tertiary General, Hefei
Registry updated 2026-11-05
NCT07670416
A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes
Trial Treatment · Phase 3 · Hoffmann-La Roche
Peking University People's Hospital, Beijing · The Second Hospital of Jilin University, Changchun · The Second Affiliated Hospital Of Anhui Medical University, Hefei · The Fourth Affiliated Hospital of Harbin Medical University, Herbin · Huai'an First People's Hospital, Huai'an · Huzhou Central Hospital, Huzhou · Jinan Central Hospital, Jinan · Hebei Petro China Central Hospital, Langfang · Luoyang Third People's Hospital, Luoyang · The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing · The First Affiliated Hospital of Ningbo University(Ningbo First Hospital), Ningbo · Tongren Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai · Shanghai Fifth People's Hospital Affiliated to Fudan University, Shanghai · Shanghai East Hospital, Shanghai · Shanghai Tenth People's Hospital, Shanghai · The People's Hospital of Liaoning Province, Shenyang · Shenyang Fifth People Hospital, Shenyang · Hebei Medical University - The Second Hospital, Shijiazhuang · Yan'an University Xianyang Hospital, Xianyang · The Second Affiliated Hospital of Zhengzhou University, Zhengzhou · Zibo Municipal Hospital, Zibo
Registry updated 2026-11-05
NCT07792954
A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity
Trial Treatment · Phase 3 · Pfizer
Beijing Tsinghua Changgung Hospital, Beijing · Beijing Friendship Hospital, Beijing · Beijing Pinggu Hospital, Beijing · Peking University People's Hospital, Beijing · The Second Hospital of Jilin University, Changchun · Changzhou Second People's Hospital, Changzhou · Chongqing University Three Gorges Hospital, Chongqing · Chongqing People's Hospital, Chongqing · Hangzhou First People's Hospital, Hangzhou · The Fourth Hospital of Harbin Medical University, Harbin · The Second People's Hospital of Hefei, Hefei · Harrison International Peace Hospital, Hengshui · Huizhou Central People's Hospital, Huizhou · Huzhou Central Hospital, Huzhou · Jinan Central Hospital, Jinan · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang · Luoyang First People's Hospital, Luoyang · Jiangxi Provincial People's Hospital, Nanchang · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · Nanjing First Hospital, Nanjing · Affiliated Hospital of Nantong University, Nantong · The First Affiliated Hospital of Ningbo University, Ningbo · Pingxiang People's Hospital, Pingxiang · Zhongshan Hospital,Fudan University, Shanghai · The Fifth People's Hospital of Shanghai, Shanghai · Shanghai Tenth People's Hospital, Shanghai · Pudong New Area People's Hospital Shanghai, Shanghai · The Second Hospital of Hebei Medical University, Shijiazhuang · Shiyan Taihe Hospital, Shiyan · Tianjin Medical University General Hospital, Tianjin · Wuhan Third Hospital, Wuhan · The First Affiliated Hospital of Xi'an Medical University, Xi'an · The Second Affiliated Hospital of Zhengzhou University, Zhengzhou · Affiliated Hospital of Jiangsu University, Zhenjiang
Registry updated 2026-11-05
NCT07794579
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Trial Treatment · Phase 3 · Eli Lilly and Company
Sichuan Provincial People's Hospital, Chengdu · The Second People's Hospital of Hefei, Hefei · The First Affiliated Hospital of Anhui Medical University, Hefei · Jinan Central Hospital, Jinan · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang Shi · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · Nanjing First Hospital, Nanjing · Jiangsu Province Official Hospital, Nanjing · Ningbo First Hospital, Ningbo · The First Hospital of Qinhuangdao, Qinhuangdao Shi · Tianjin Medical University Zhu Xianyi Memorial Hospital, Tianjin
Registry updated 2026-11-05
NCT07873645
Study of UBT37034 Injection
Trial Treatment · Phase 1 · The United Bio-Technology (Hengqin) Co., Ltd.
The Third Xiangya Hospital of Central South University, Changsha
Registry updated 2026-11-05
NCT07898267
Gut Microbiota-Based Clinical Study of Akkermansia Supplementation for Overweight and Obesity
Trial Treatment · Second Affiliated Hospital of Nanchang University
No. 1, Minde Road, Donghu District, Nanchang University Second Affiliated Hospital, Nanchang
Registry updated 2026-11-05
NCT07918625
A Study to Evaluate Efficacy and Safety of BGM1812 Injection in Overweight or Obese Participants Without Diabetes
Trial Treatment · Phase 2 · BrightGene Bio-Medical Technology Co., Ltd.
The Second Affiliated Hospital of Soochow University, Changsha
Registry updated 2026-11-05
NCT06672549
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Trial Treatment · Phase 3 · Eli Lilly and Company
National Cheng Kung University Hospital, Tainan · National Taiwan University Hospital, Taipei · Chang Gung Medical Foundation-Linkou Branch, Taoyuan
Registry updated 2026-11-04
NCT07202884
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Trial Treatment · Phase 3 · Eli Lilly and Company
Peking University People's Hospital, Beijing · Xuanwu Hospital, Capital Medical University, Beijing · Peking University First Hospital, Beijing · Peking University Third Hospital, Beijing · Chengdu Women and Children Center Hospital, Chengdu · Sichuan Provincial People's Hospital, Chengdu · 2nd Affiliated Hospital Chongqing Medical University, Chongqing · Zhujiang Hospital, Guangzhou · The First Affiliated Hospital of Jinan University, Guangzhou · Zhejiang Provincial People's Hospital, Hangzhou · Second Affiliated hospital of Anhui Medical University, Hefei · Gansu Provincial Hospital, Lanzhou · Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing · Ningbo First Hospital, Ningbo · Obstetrics&Gynecology Hospital of Fudan University, Shanghai · Peking University Shenzhen Hospital, Shenzhen · The Second Affiliated Hospital of Soochow University, Suzhou · Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan · The First Affiliated hospital of Xiamen University, Xiamen · The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an
Registry updated 2026-11-04
NCT07282600
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Beijing Pinggu District Hospital, Beijing · Peking University People's Hospital, Beijing · Luhe Hospital, Beijing · Sichuan Provincial People's Hospital, Chengdu · The Second Affiliated Hospital Chongqing Medical University, Chongqing · Zhujiang Hospital, Guangzhou · The Second People's Hospital of Hefei, Hefei · Jinan Central Hospital, Jinan · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang Shi · Jiangxi Provincial People's Hospital, Nanchang · Jiangsu Province Official Hospital, Nanjing · Nanjing First Hospital, Nanjing · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · Jiading District Central Hospital, Shanghai · The Second Hospital of Tianjin Medical University, Tianjin · Zigong First People's Hospital, Zigong
Registry updated 2026-11-04
NCT07353931
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Trial Treatment · Phase 3 · Eli Lilly and Company
Beijing Ji Shui Tan Hospital, Beijing · The First Afflilated Hospital of Bengbu Medical College, Bengbu · Jilin Province People's Hospital, Changchun · The Second Hospital of Jilin University, Changchun · Xiangya Hospital Central South University, Changsha · 2nd Affiliated Hospital Chongqing Medical Universi, Chongqing · The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou · The Second People's Hospital of Hefei, Hefei · Jinan Central Hospital, Jinan · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang · Nanjing First Hospital, Nanjing · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · Zhongda Hospital Southeast University, Nanjing · Jiangsu Province Hospital, Nanjing · The First Affiliated Hospital of Ningbo University, Ningbo · Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai · Huashan Hospital, Fudan University, Shanghai · Zhongshan Hospital,Fudan University, Shanghai · The Second Affiliated Hospital of Soochow University, Suzhou · Tianjin Hospital, Tianjin · The 2nd Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou · Tongji Hospital Tongji Medical,Science & Technology, Wuhan · Xianyang Hospital of Yan'an University, Xianyang
Registry updated 2026-11-04
NCT07369011
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Trial Treatment · Phase 3 · Eli Lilly and Company
China-Japan Friendship Hospital, Beijing · The Second Hospital of Jilin University, Changchun · The First Hospital of Jilin University, Changchun · The Third Xiangya Hospital of Central South University, Changsha · Sichuan Provincial People's Hospital, Chengdu · The First Affiliated Hospital of Chongqing Medical University, Chongqing · The First Affiliated Hospital of Guangzhou Medical University, Guangzhou · The Second People's Hospital of Hefei, Hefei · The First People's Hospital of Yunnan Province, Kunming · Gansu Provincial Hospital, Lanzhou · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang Shi · Jiangxi Provincial People's Hospital, Nanchang · Nanjing First Hospital, Nanjing · The Second Affiliated Hospital of Guangxi Medical University, Nanning · Ningbo First Hospital, Ningbo · Shanghai Sixth People's Hospital, Shanghai · Shanghai East Hospital, Shanghai · Shenzhen People's Hospital, Shenzhen · Shenzhen Hospital of Southern Medical University, Shenzhen · The Second Affiliated Hospital of Soochow University, Suzhou · Wuxi People's Hospital, Wuxi · Xianyang Hospital of Yan'an University, Xianyang
Registry updated 2026-11-04
NCT07392190
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Trial Treatment · Phase 3 · Eli Lilly and Company
The First Hospital of Jilin University, Changchun · The Second Hospital of Jilin University, Changchun · The Second Xiangya Hospital of Central South University, Changsha · West China Hospital，Sichuan University, Chengdu · Sichuan Provincial People's Hospital, Chengdu · 2nd Affiliated Hospital Chongqing Medical Universi, Chongqing · Zhujiang Hospital, Guangzhou · The Affiliated Hospital of Guizhou Medical University, Guiyang · The Second People's Hospital of Hefei, Hefei · Huzhou Central Hospital, Huzhou · Jinan Central Hospital, Jinan · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang Shi · Affiliated Hospital of Luzhou Medical College, Luzhou · Jiangxi Provincial People's Hospital, Nanchang · Nanjing First Hospital, Nanjing · Zhongda Hospital Southeast University, Nanjing · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · Ningbo First Hospital, Ningbo · Zhongshan Hospital,Fudan University, Shanghai · The 2nd Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou · The Central Hospital of Wuhan, Wuhan · Xianyang Hospital of Yan'an University, Xianyang
Registry updated 2026-11-04
NCT07697391
AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes
Trial Treatment · Phase 4 · The First Affiliated Hospital of Anhui Medical University
The First Affiliated Hospital of Chongqing Medical University, Chongqing · The First Affiliated Hospital of Anhui Medical University, Hefei · The Second Affiliated Hospital Of Anhui Medical University, Hefei · First Hospital of Shanxi Medical University, Taiyuan · The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
Registry updated 2026-11-04
NCT07881458
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
The Second Hospital of Jilin University, Changchun · Jinan Central Hospital, Jinan · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang Shi · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · Ningbo First Hospital, Ningbo · The First Hospital of Hebei Medical University, Shijiazhuang · Tianjin Medical University Zhu Xianyi Memorial Hospital, Tianjin
Registry updated 2026-11-04
NCT07916194
A Study of Zovaglutide (ZT002 Injection) in Participants With Hepatic Impairment and Healthy Participants
Trial Treatment · Phase 1 · Beijing QL Biopharmaceutical Co.,Ltd
Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital, Chengdu · The Second Affiliated Hospital of Chongqing Medical University, Chongqing · Henan Infectious Diseases Hospital , The Sixth People's Hospital of Zhengzhou, Zhengzhou
Registry updated 2026-11-04
NCT07134335
UBT251 Injection Phase II Clinical Study (CKD)
Trial Treatment · Phase 2 · The United Bio-Technology (Hengqin) Co., Ltd.
Peking University First Hospital, Beijing
Registry updated 2026-11-03
NCT07844512
Safety and Analgesic Efficacy of the Biased μ-Opioid Receptor Agonist Tegileridine for Post-Operative Analgesia in Patients Undergoing Bariatric Surgery
Trial Treatment · Phase 3 · The First Hospital of Jilin University
The First Hospital of Jilin University, Changchun
Registry updated 2026-11-03
NCT07881432
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Peking University First Hospital, Beijing · Peking University People's Hospital, Beijing · Luhe Hospital, Beijing · The Second Hospital of Jilin University, Changchun · The Third Xiangya Hospital of Central South University, Changsha · Sichuan Provincial People's Hospital, Chengdu · 2nd Affiliated Hospital Chongqing Medical Universi, Chongqing · Zhujiang Hospital, Guangzhou · The First Affiliated Hospital of Jinan University, Guangzhou · The Second People's Hospital of Hefei, Hefei · Jinan Central Hospital, Jinan · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang · Affiliated Hospital of Luzhou Medical College, Luzhou · Jiangxi Provincial People's Hospital, Nanchang · Nanjing Medical University - Nanjing Jiangning Hospital, Nanjing · Nanjing First Hospital, Nanjing · Jiangsu Province Official Hospital, Nanjing · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · The First Affiliated Hospital of Nanyang Medical College, Nanyang · Ningbo First Hospital, Ningbo · The First Hospital of Qinhuangdao, Qinhuangdao Shi · Jiading District Central Hospital, Shanghai · The First Hospital of Hebei Medical University, Shijiazhuang · The First Affiliated Hospital of Soochow University, Suzhou · Xianyang Hospital of Yan'an University, Xianyang
Registry updated 2026-11-03
NCT07900633
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Trial Treatment · Phase 3 · Eli Lilly and Company
Xuanwu Hospital, Capital Medical University, Beijing · Peking University Third Hospital, Beijing · West China Hospital，Sichuan University, Chengdu · Sichuan Provincial People's Hospital, Chengdu · Zhujiang Hospital, Guangzhou · The Second Affiliated Hospital of Zhejiang University School of Medicine - Jiefanglu Campus, Hangzhou · The First Hospital of Harbin Medical University, Harbin · Jinan Central Hospital, Jinan · Panjin Liaoyou Baoshihua Hospital, Liaoyou · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang Shi · Zhongda Hospital Southeast University, Nanjing · Nanjing First Hospital, Nanjing · Jiading District Central Hospital, Shanghai · Shanghai Putuo District Center Hospital, Shanghai · The Third Hospital of Hebei Medical University, Shijiazhuang · Hebei General Hospital, Shijiazhuang · Tianjin Medical University General Hospital, Tianjin · The 2nd Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou · The Affiliated Hospital of Xuzhou Medical College, Xuzhou · The Second People's Hospital of Yibin, Yibin · Zigong First People's Hospital, Zigong
Registry updated 2026-11-03
NCT07908823
ERCG vs Intensive Lifestyle Intervention for Weight Regain After GLP-1 RA Discontinuation
Trial Treatment · Affiliated Hospital to Academy of Military Medical Sciences
The Fifth medical center of Chinese PLA General Hospital, Beijing
Registry updated 2026-11-02
NCT07784725
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Trial Treatment · Phase 3 · AstraZeneca
Beijing · Cangzhou · Changchun · Changsha · Chengdu · Danyang · Ganzhou · Guiyang · Hengshui · Huizhou · Lanzhou · Panjin · Qiqihar · Shanghai · Suzhou · Xiamen · Xianyang · Zigong
Registry updated 2026-10-30
NCT07850063
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
Trial Treatment · Phase 3 · Boehringer Ingelheim
West China Hospital，Sichuan University, Chengdu · The First Affiliated Hospital of Henan University of Science and Technology, Luoyang · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · Shanghai Tenth People's Hospital, Shanghai · Zhongshan Hospital Affiliated to Fudan University, Shanghai
Registry updated 2026-10-30
NCT07907029
Transcutaneous Auricular Vagus Nerve Stimulation Combined With Lifestyle Intervention for Visceral Fat Reduction in Adults With Overweight or Obesity
Trial Treatment · Guangdong Provincial Hospital of Traditional Chinese Medicine
Zhuhai Hospital, Guangdong Provincial Hospital of Chinese Medicin, Zhuhai
Registry updated 2026-10-30
NCT07037459
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Trial Treatment · Phase 3 · Amgen
First Affiliated Hospital of Baotou Hospital, Inner, Baotou · Beijing Friendship Hospital, Capital Medical University, Beijing · Beijing Hospital, Beijing · Peking University Third Hospital, Beijing · Fuwai Hospital Chinese Academy of Medical Sciences, Beijing · China-Japan Union Hospital of JiLin University, Changchun · The First Bethune Hospital of Jilin University, Changchun · Jilin Province Peoples Hospital, Changchun · The Second Hospital of Jilin University, Changchun · The Third Hospital of Changsha, Changsha · The Second Xiangya Hospital of Central South University, Changsha · The Third Xiangya Hospital of Central South University, Changsha · The First Peoples Hospital of Changzhou, Changzhou · Chengdu Fifth Peoples Hospital, Chengdu · Affiliated Hospital of Chifeng University, Chifeng · The Second Affiliated Hospital of Chongqing Medical University, Chongqing · Daqing Oilfield General Hospital, Daqing · Guangdong Provincial Peoples Hospital, Guangzhou · The Affiliated Hospital of Inner Mongolia Medical University, Haikou · The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou · Sir Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou · The First Affiliated Hospital of Harbin Medical University, Harbin · The Second Hospital of Anhui Medical University, Hefei · Hebei Petro China Central Hospital, Hengyang · Qilu Hospital of Shandong University, Jinan · Jinan Central Hospital, Jinan · Huaihe Hospital of Henan University, Kaifeng · Lishui Central Hospital, Lishui · Luoyang Third Peoples Hospital, Luoyang · The First Affiliated Hospital of NanChang University, Nanchang · Zhongda Hospital Southeast University, Nanjing · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · Pingxiang Peoples Hospital, Pingxiang · First Hospital of Qinhuangdao, Qinhuangdao · Shanghai Tenth Peoples Hospital, Shanghai · Shanghai General Hospital, Shanghai · Shanghai East Hospital, Shanghai · Zhongshan Hospital Affiliated to Dalian University, Shenyang · The Peoples Hospital of Liaoning Province, Shenyang · The Second Hospital of Hebei Medical University, Shijiazhuang · The First Hospital of Hebei Medical University, Shijiazhuang · Siping City Center Peoples Hospital, Siping · Tai'an City Central Hospital, Tai’an · First Hospital of Shanxi Medical University, Taiyuan · Shanxi Cardiovascular Hospital, Taiyuan · Tianjin Peoples Hospital, Tianjin · TEDA International Cardiovascular Hospital, Tianjin · The Third Peoples Hospital of Hubei Province, Wuhan · Wuxi Peoples Hospital, Wuxi · The First Affiliated Hospital of Xi'an Medical University, Xi'an · Shaanxi Provincial Peoples Hospital, Xi'an · The First Affiliated Hospital of Xi'an Jiao Tong University, Xi’an · Yuncheng Central Hospital, Yuncheng · The First Affiliated Hospital of Zhengzhou University, Zhengzhou · Zhengzhou Central Hospital, Zhengzhou
Registry updated 2026-10-29

All Obesity trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error